Netherlands· NL-9b1c70555036
Stocrin 50 mg, capsules
A efavirenz product containing efavirenz, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Efavirenz is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Efavirenz · ATC J05AG03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of efavirenz costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Efavirenz · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- FR France$66.82
- CH Switzerland$9.90
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- EFAVIRENZ
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Netherlands (NL)
- ATC code
- J05AG03
- ATC class
- Efavirenz
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 15, 2026
Packs & prices · 1
- cbg_meb_idEU/1/99/111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
486 interactions on record for efavirenz.
Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Efavirenz · interactions on record
486 records
- 137 severe
- 278 moderate
- 8 minor
- 48 info
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
15 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Efavirenz in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandStocrinMerck Sharp & Dohme B.V.
- BelgiumStocrin 50 mgMerck Sharp & Dohme
- SpainSUSTIVA 50 mg, CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- FranceSUSTIVA 50 mg, géluleBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- United KingdomSustiva 50mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- PolandSustivaBristol-Myers Squibb Pharma EEIG
- United StatesEfavirenzAurobindo Pharma Limited
- DenmarkSustivaBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Efavirenz Sandoz
- Belgium · Efavirenz Viatris
- Cyprus · Efavirenz Aurobindo
- Germany · Efavirenz Aurobindo
- Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
- Estonia · Efavirenz Sandoz
- Spain · Efavirenz Aurovitas
- Finland · Efavirenz Aurobindo, Efavirenz Sandoz
- France · Efavirenz Arrow, Efavirenz Sandoz
- United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
- Iceland · Efavirenz Teva
- Liechtenstein · Efavirenz Teva
- Norway · Efavirenz Sandoz, Efavirenz Teva
- Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
- Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d983daa5-1f67-40b5-a8f4-dee8d364dd40 GET /v1/drugs/d983daa5-1f67-40b5-a8f4-dee8d364dd40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/stocrin-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Efavirenz",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70516",
"excipients": [
"CARMINEZUUR (E 120)",
"GELATINE (E 441)",
"IJZEROXIDE GEEL (E 172)",
"INDIGOKARMIJN (E 132)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMLAURILSULFAAT",
"NATRIUMLAURILSULFAAT",
"NATRIUMZETMEELGLYCOLAAT",
"PAARSE INKT",
"SILICA, HYDRATE FORM UNKNOWN (E 551)",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"EFAVIRENZ"
],
"leaflet_url": null,
"authorised_at": "1999/05/28",
"procedure_number": "EMEA/H/C/000250",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/99/111",
"additional_monitoring": "N"
}See everything about efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.